Management of Elevated Triglyceride Levels
Classification and Risk Assessment
- A triglyceride level of 359 mg/dL falls into the "high" category, which is associated with increased cardiovascular risk but below the threshold for acute pancreatitis concern 1
- This level indicates atherogenic remnant lipoproteins and apolipoprotein CIII-enriched particles that contribute to cardiovascular disease risk 1
- High triglycerides serve as a biomarker for visceral adiposity, insulin resistance, diabetes, and nonalcoholic hepatic steatosis 1
Initial Evaluation
- Evaluate for secondary causes of hypertriglyceridemia, including uncontrolled diabetes, hypothyroidism, renal disease, excessive alcohol intake, medications, and liver disease 3, 4, 5, 6
- Assess for other cardiovascular risk factors to determine overall risk profile 6
- Rule out medications as potential causes of elevated triglycerides 2
Lifestyle Interventions
- Implement intensive therapeutic lifestyle changes as first-line therapy, which can reduce triglyceride levels by up to 50% 2, 5
- Target a 5-10% reduction in body weight, which can reduce triglycerides by approximately 20% 3, 4
- Reduce carbohydrate intake, particularly added sugars and fructose 2
- Increase unsaturated fat intake while restricting saturated and trans fats 2
- Increase consumption of marine-based omega-3 products 2
- Engage in regular aerobic activity (at least 150 minutes/week of moderate-intensity exercise) 3
- Limit or completely avoid alcohol consumption 2, 3
Pharmacological Therapy
- If triglyceride levels remain elevated after 3 months of lifestyle modifications, consider pharmacological intervention 4
- For triglyceride levels between 200-499 mg/dL with increased cardiovascular risk, statins are first-line therapy if LDL-C is also elevated 7
- Consider adding icosapent ethyl to statin therapy to further reduce cardiovascular risk 6
- Fibrates are the most potent triglyceride-lowering agents (reducing levels by up to 50%) and should be considered if triglycerides remain elevated despite other interventions 7
Special Considerations
- Statin plus fibrate combination therapy has not been shown to improve cardiovascular outcomes and is generally not recommended due to increased risk of myopathy 6
- If diabetes is present, optimizing glycemic control can significantly improve triglyceride levels 3, 4
- For women taking oral contraceptives who develop hypertriglyceridemia, consider lower estrogen-containing preparations or alternative contraception methods 2